Guardant Health
GH
#1765
Rank
A$17.36 B
Marketcap
A$133.69
Share price
-0.14%
Change (1 day)
110.49%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): A-$5.02

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$4.50. In 2024 the company made an earnings per share (EPS) of A-$5.00 an increase over its 2023 EPS that were of A-$6.01.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.020.41%
2024A-$5.00-16.82%
2023A-$6.01-33.13%
2022A-$8.9860%
2021A-$5.6155.04%
2020A-$3.62207.14%
2019A-$1.18-19.81%
2018A-$1.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
A-$3.89-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A-$3.00-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA